ASH1 like histone lysine methyltransferase
ASH1L encodes a large, multi-domain chromatin regulator with separable recruitment, reader, catalytic, and chromatin-engagement functions.
Gene, protein & dosage →FAMILY-FOUNDED · INTERNATIONAL · EVIDENCE-LED
A public clinical and translational research hub connecting a governed 61-person cohort with longitudinal evidence, public variant data, and testable biology—without separating a claim from its denominator, source, or uncertainty.
Current anchor61 de-identified people19 countriesevidence reviewed July 23, 2026

Roster-level architecture—not phenotype prevalence.
START HERE · WHAT IS ASH1L?
Its established human disease association is neurodevelopmental. The open scientific question is how specific molecular findings change ASH1L function across cell types, developmental windows, physiological states, and time.
ASH1L encodes a large, multi-domain chromatin regulator with separable recruitment, reader, catalytic, and chromatin-engagement functions.
Gene, protein & dosage →A disease-causing change in one copy can produce autosomal-dominant ASH1L-related neurodevelopmental disorder. Gene-level dosage evidence does not make every allele equivalent.
ClinGen dosage evidence ↗Development, communication, learning, behavior, sleep, movement, seizures, and broader multisystem findings vary across people and across age.
Genotype × phenotype × time →ONE COHORT · FOUR EVIDENCE DEPTHS
These are nested documentation depths, not four estimates of the same thing. A detailed result from a record-rich person cannot be promoted to the 61-person denominator.
The full person-level anchor.
At least one mapped clinical observation.
The strict clinical-depth subset.
Age-ordered, detail-rich reconstructions.
Unreported is not negative. A mapped observation is not automatically record-backed. A recurring molecular finding is not automatically an independent family event.
Evidence, denominators & privacy →HOW THIS HUB READS ASH1L
Molecular architecture, clinical systems, chronology, and evidence class stay connected. Removing any one of them can create a stronger-looking but less valid conclusion.
LoF/truncating, missense, CNV/deletion, complex/mixed, splice/protein-undefined, and pending contexts are not analytically interchangeable.
Open this layer →Fifteen lanes preserve development, neurology, sleep, GI, ENT, movement, immune, autonomic, growth, medication, school, and adult function.
Open this layer →Age, illness, sleep, fuel state, hormones, procedures, medication, and recovery can change what is measurable.
Open this layer →Formal records, reported formal content, parent observation, controls, unresolved findings, and hypotheses remain visibly separate.
Open this layer →SEVEN CLINICAL CHAPTERS · FIFTEEN LANES UNDERNEATH
The chapter pages organize readable clinical domains. The underlying atlas preserves the full fifteen-lane evidence architecture and the exact mapping state for every person-lane cell.
Milestones, learning, retention, retrieval, reliable access, regression, school, and adult function.
Event types, EEG, sleep, unresolved spells, nonepileptic controls, triggers, and recovery.
Tone, feet, laterality, pain, tics, stereotypies, mobility, rehabilitation, and recovery.
Chewing, swallowing, dentition, bowel and fuel state, hearing, airway, growth, and bone.
Infection, antibody response, inflammatory assays, allergy, barrier tissues, bruising, and repair.
Rhythm, ECG, syncope, orthostatic physiology, breathing, temperature, sweating, and urinary events.
Diagnoses, anxiety, mood, aggression, rigidity, self-injury, sensory regulation, medical mimics, and treatment response.
BIOLOGY WITHOUT OVERREACH
The Biology page separates the human-genetic anchor from direct molecular evidence, model-system findings, and the hypotheses that require patient-allele, time-resolved, rescue-supported experiments.
ASH1L has a definitive autosomal-dominant neurodevelopmental gene–disease relationship, and haploinsufficiency is an established mechanism.
Protein structure, chromatin biochemistry, neural-cell perturbation, and tissue models define specific functions and assays.
Allele, cell identity, developmental state, time course, and rescue must be connected before a shared mechanism can be claimed.
CURRENT PROGRAM
Each destination owns one analytic job. Summary pages link to the detail instead of reproducing it.
Age, sex, countries, molecular architecture, and canonical subsets.
Who is represented →02Public molecular architecture, recurrence, familial structure, co-findings, and analytic boundaries.
Review the landscape →03Age-anchored observations and load-state windows with incomplete pre/post capture left visible.
Follow change over time →04Mechanism, natural history, modifiers, biomarkers, endpoints, and study design.
See what needs testing →START BY ROLE
FAMILIES
CLINICIANS
RESEARCHERS
FOR ASH1L FAMILIES
Connect with other ASH1L parents. Community participation is separate from research consent or medical-record sharing.